Clearance Summary
STAGO FACTOR XII-DEFICIENT PLASMA received FDA 510(k) clearance under submission number K933438, sponsored by American Bioproducts Co.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 1993-10-27.
- Submission: K933438
- Applicant / Sponsor: American Bioproducts Co.
- Clearance pathway: Traditional
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7290
- Decision date: 1993-10-27
Classification & Regulation
This clearance is catalogued under FDA product code GJT and 21 CFR 864.7290, within the Hematology review panel as a Class II device.